Ocugen, INC 8-K filings

Ocugen announces a board member's departure and a change to the company's bylaws, reducing the quorum requirement for stockholder meetings.

Ocugen, Inc. has announced the appointment of Dr. Huma Qamar as its new Chief Medical Officer, effective March 18, 2024.

Ocugen presented a clinical showcase highlighting their gene therapy programs, including OCU400 for retinitis pigmentosa and Leber congenital amaurosis, and provided updates on their pipeline and market potential.